Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
TCERG1 pseudogene 1 (TCERG1P1) is a human pseudogene and not a protein-coding gene. It is homologous to the functional gene TCERG1, which encodes a nuclear protein involved in the regulation of transcriptional elongation and pre-mRNA splicing by RNA polymerase II[2][1]. Unlike TCERG1, the pseudogene TCERG1P1 is not known to be expressed as a functional protein and has no established biological or pharmacological function. There is no evidence that TCERG1P1 itself serves as a therapeutic target, biomarker, or has roles in drug interaction or disease association. References that discuss disease mechanisms, drug targeting, or biological function almost always refer to the parental gene TCERG1, not TCERG1P1[2][1]. For structured data and target evaluation, the canonical form “TCERG1 pseudogene 1” should be flagged as a pseudogene and not a biological target.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on TCERG1 pseudogene 1 (TCERG1P1).